[HTML][HTML] Effects of lixisenatide once daily on gastric emptying in type 2 diabetes—relationship to postprandial glycemia
M Lorenz, C Pfeiffer, A Steinsträßer, RHA Becker… - Regulatory peptides, 2013 - Elsevier
Objectives To determine the effects of lixisenatide, a new once-daily (QD) glucagon-like
peptide-1 receptor agonist, on postprandial glucose (PPG) and gastric emptying, and the
relationship between these effects in patients with type 2 diabetes mellitus (T2DM). Methods
Data were obtained from a randomized, double-blind, placebo-controlled, parallel-group
study with treatment duration of 28 days in patients with T2DM receiving≤ 2 oral antidiabetic
drugs. Lixisenatide was injected subcutaneously using an ascending dose range (5–20 μg) …
peptide-1 receptor agonist, on postprandial glucose (PPG) and gastric emptying, and the
relationship between these effects in patients with type 2 diabetes mellitus (T2DM). Methods
Data were obtained from a randomized, double-blind, placebo-controlled, parallel-group
study with treatment duration of 28 days in patients with T2DM receiving≤ 2 oral antidiabetic
drugs. Lixisenatide was injected subcutaneously using an ascending dose range (5–20 μg) …